Home > > Pharmaceuticals And Healthcare > > Absorbable Surgical Sutures Market Size, Trends | Statistics Report, 2031
Id: CBI_1551 | Pages: 222 | Format : PDF | Published : | Author : Pawan Chasta | Category : Pharmaceuticals And Healthcare
Absorbable Surgical Sutures Market size is estimated to reach over USD 5.08 Billion by 2031 from a value of USD 3.01 Billion in 2023 and is projected to grow by USD 3.16 Billion in 2024, growing at a CAGR of 6.7% from 2024 to 2031.
Absorbable surgical sutures are specialized medical threads designed to dissolve naturally in the body over time, eliminating the need for suture removal after surgery. These sutures are made from materials like polyglycolic acid, polylactic acid, and catgut, which are absorbed by the body through enzymatic or hydrolytic processes. Absorbable sutures are widely used in surgeries where internal tissues require temporary support during healing, such as gastrointestinal, gynecological, and orthopedic procedures. Their use reduces the risk of infection and minimizes patient discomfort compared to non-absorbable alternatives. Advancements in suture materials and technologies have enhanced the performance and safety of these sutures. End-use sectors such as hospitals, surgical centers, and specialty clinics are key adopters, as absorbable sutures continue to play a vital role in improving surgical outcomes and patient recovery.
With the growing prevalence of chronic diseases such as cancer, cardiovascular disorders, and orthopedic conditions, the need for surgeries continues to rise, particularly in both developed and emerging economies. Absorbable sutures are preferred in many surgical procedures, including gastrointestinal, gynecological, and orthopedic surgeries, due to their ability to dissolve naturally within the body, eliminating the need for suture removal. The trend toward minimally invasive surgeries has also increased the adoption of absorbable sutures, which offer faster healing and reduce the risk of infection compared to non-absorbable alternatives. The absorbable surgical sutures market growth is further supported by advancements in suture material technology, such as synthetic and antimicrobial-coated sutures, which enhance performance and reduce complications.
One of the major restraints limiting the market is the high cost associated with advanced suture materials, particularly synthetic absorbable sutures. While traditional absorbable sutures made from natural materials like catgut are more affordable, newer synthetic alternatives, such as polyglycolic acid (PGA) and polydioxanone (PDO), come at a higher cost. This makes them less accessible, especially in low-income and rural healthcare settings where budget constraints are more pronounced. Additionally, the cost factor can limit their widespread adoption in regions with less-developed healthcare infrastructure, where cost-effective solutions are prioritized. Healthcare providers in these regions may opt for cheaper non-absorbable sutures, further restraining absorbable surgical sutures market demand.
Emerging markets, particularly in Asia-Pacific and Latin America, present significant absorbable surgical sutures market opportunities. As healthcare infrastructure improves and access to surgical treatments expands in these regions, the need for advanced surgical products, including absorbable sutures, is rising. Additionally, the increasing focus on outpatient surgeries and day-care procedures in developed markets is further boosting demand for absorbable sutures. These sutures are favored in outpatient settings due to their ability to reduce the need for follow-up visits for suture removal, leading to better patient outcomes and cost savings for healthcare providers. The growing trend toward outpatient care, combined with the rising number of surgical procedures in emerging regions, is expected to offer substantial opportunities for absorbable surgical sutures market expansion.
Based on product type, the market is segmented into monofilament sutures and multifilament (braided) sutures.
The monofilament sutures segment accounted for the largest revenue share of the total absorbable surgical sutures market share in 2023.
The multifilament (braided) sutures segment is anticipated to register the fastest CAGR during the forecast period.
Based on material, the market is segmented into synthetic sutures (polyglycolic acid (PGA), polyglactin 910, polydioxanone (PDO), polyglytone, others) and natural sutures.
The synthetic sutures segment accounted for the largest revenue share of the overall absorbable surgical sutures market share in 2023.
The polydioxanone (PDO) segment is anticipated to register the fastest CAGR during the forecast period.
Based on application, the market is segmented into cardiovascular surgery, general surgery, orthopedic surgery, gynecological surgery, ophthalmic surgery, and others.
The cardiovascular surgery segment accounted for the largest revenue share of 35.18% in 2023.
The orthopedic surgery segment is anticipated to register the fastest CAGR during the forecast period.
Based on end-user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others.
The hospitals segment accounted for the largest revenue share in 2023.
The ambulatory surgical centers segment is anticipated to register the fastest CAGR during the forecast period.
The regions covered are North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
Asia Pacific region was valued at USD 0.70 Billion in 2023. Moreover, it is projected to grow by USD 0.74 Billion in 2024 and reach over USD 1.26 Billion by 2031. Out of this, China accounted for 32.5% of the total market share. Asia-Pacific is the fastest-growing region in the market, driven by increasing healthcare investments and the rising number of surgeries in countries like China, India, and Japan. Rapidly expanding healthcare infrastructure, along with a growing elderly population and increasing prevalence of chronic conditions, supports market development. Government initiatives to improve healthcare access in rural areas further stimulate demand for absorbable sutures. However, limited access to advanced surgical technologies in certain regions and a shortage of skilled surgeons may hinder growth.
North America holds a dominant position in the market, driven by the high volume of surgical procedures performed in the U.S. and Canada, particularly in orthopedic and cardiovascular surgeries. The region benefits from a well-established healthcare infrastructure and strong investments in advanced surgical technologies. The aging population and high prevalence of chronic diseases further boost demand for absorbable sutures. However, market growth may be challenged by the increasing use of minimally invasive surgical techniques, which require fewer sutures.
Europe represents a significant market for absorbable surgical sutures, with Germany, France, and the UK leading due to the region's advanced healthcare systems and rising demand for surgical interventions. The high prevalence of cardiovascular diseases and orthopedic disorders among the aging population drives the need for surgical sutures. Additionally, innovations in suture materials and government initiatives to improve healthcare quality contribute to market expansion. However, stringent regulations and the high costs of advanced surgical sutures can slow market growth.
The Middle East & Africa region is witnessing moderate growth in the market, particularly in Saudi Arabia, the UAE, and South Africa. Growing investments in healthcare infrastructure and the rising demand for advanced surgical solutions drive market. The increasing prevalence of chronic diseases and an aging population have led to a higher demand for surgical interventions. However, limited healthcare access and the high cost of advanced sutures in certain regions remain challenges to absorbable surgical sutures market expansion.
Latin America is an emerging market for absorbable surgical sutures, with Brazil and Mexico being key contributors. The region's growth is driven by the rising number of surgical procedures, particularly in the areas of orthopedics, gynecology, and general surgeries. An increasing focus on improving healthcare infrastructure and access to surgical care supports market growth. However, economic instability and a lack of advanced surgical equipment in some countries may restrict market expansion in the region.
The absorbable surgical sutures market is highly competitive with major players providing products to the national and international markets. Key players are adopting several strategies in research and development (R&D), product innovation, and end-user launches to hold a strong position in the global absorbable surgical sutures market. Key players in the absorbable surgical sutures industry include-
Business Expansion:
Product Launch:
Approvals:
Report Attributes | Report Details |
Study Timeline | 2018-2031 |
Market Size in 2031 | USD 5.08 Billion |
CAGR (2024-2031) | 6.7% |
By Product Type |
|
By Material |
|
By Application |
|
By End-User |
|
By Region |
|
Key Players |
|
North America | U.S. Canada Mexico |
Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
Middle East and Africa | GCC Turkey South Africa Rest of MEA |
LATAM | Brazil Argentina Chile Rest of LATAM |
Report Coverage |
|
Absorbable Surgical Sutures Market size is estimated to reach over USD 5.08 Billion by 2031 from a value of USD 3.01 Billion in 2023 and is projected to grow by USD 3.16 Billion in 2024, growing at a CAGR of 6.7% from 2024 to 2031.
Absorbable surgical sutures are used to close internal wounds or surgical incisions. They are designed to break down naturally within the body over time, eliminating the need for removal and reducing the risk of post-surgical complications. They are commonly used in procedures such as gastrointestinal, gynecological, and orthopedic surgeries.
The Asia-Pacific region is expected to witness the highest growth in the market due to the rising number of surgeries, improving healthcare infrastructure, and increasing awareness about advanced surgical techniques in countries like India and China.
Key trends include the development of sutures made from synthetic materials like polyglycolic acid and polydioxanone, which offer better strength and controlled degradation. Additionally, innovations in antibacterial sutures are gaining traction, helping to reduce infection rates in post-operative wounds.